EE275 Number Needed to Treat Analysis of Nivolumab Versus Surveillance for the Adjuvant Treatment of Patients with Resected Esophageal Cancer (EC) or Gastroesophageal Junction Cancer (GEJC)
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.521
https://www.valueinhealthjournal.com/article/S1098-3015(22)00722-7/fulltext
Title :
EE275 Number Needed to Treat Analysis of Nivolumab Versus Surveillance for the Adjuvant Treatment of Patients with Resected Esophageal Cancer (EC) or Gastroesophageal Junction Cancer (GEJC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00722-7&doi=10.1016/j.jval.2022.04.521
First page :
Section Title :
Open access? :
No
Section Order :
10462